Karve S, Cleves MA, Helm M, Hudson TJ, West DS, Martin BC (2009) Good and poor adherence: optimal cut-point for adherence measures using administrative claims data
This matters, because some weight thats lost during GLP-1 therapy may come from lean body mass, not just fat
Annals of Surgery, 280(3), 414-423.
RNA activation-a novel approach to therapeutically upregulate gene transcription
In a variety of cultured cells such as human Jurkat T cells human erythrocytes, C6 glial cells, NB41A3 neuroblastoma cells, and peripheral blood lymphocyte, DHLA also increases GSH synthesis by reducing the ratio of cystine to cysteine (as cysteine is the rate-limiting substrate for this reaction
GHK-Cu is delivered via subcutaneous injection, targeting areas where a natural layer of fat sits between the skin and muscle